Klarquist Secures 9-0 Decision at the United States Supreme Court for Client Nautilus
In a unanimous decision, Nautilus, Inc. v. Biosig Instruments, Inc., 13-369 (June 2, 2014), the United States Supreme Court rejected the Federal Circuit’s “insolubly ambiguous” and “amenable to construction” test for enforcing the Patent Act’s requirement that patent claims particularly point out and distinctly claim the invention.
Nautilus is represented by Klarquist attorneys James E. Geringer, Jeffrey S. Love, John D. Vandenberg, and Philip Warrick, and in the S. Ct. also by Thomas G. Hungar, Matthew D. McGill, and Jonathan D. Bond, of Gibson, Dunn & Crutcher, LLP, in Washington, D.C.
The New York Times editorial, “Clarifying, and Tightening, Patent Law”
Opinion of the Court in Nautilus v. Biosig Instruments